-transparent.png){kind=logo}
Author Correction: Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and ΔNp63. 2021
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
December 2021,
Molecular medicine reports,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
April 2023,
Systems biology in reproductive medicine,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
December 2020,
European review for medical and pharmacological sciences,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
September 2020,
Clinical and experimental pharmacology & physiology,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
September 2019,
Journal of cellular and molecular medicine,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
January 2021,
Breast disease,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
January 2021,
Current pharmaceutical design,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
September 2020,
Molecular oncology,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
December 2020,
Artificial cells, nanomedicine, and biotechnology,
Yingjie Liu, and
Peiyuan Zhang, and
Qiuyao Wu, and
Houqin Fang, and
Yuan Wang, and
Yansen Xiao, and
Min Cong, and
Tingting Wang, and
Yunfei He, and
Chengxin Ma, and
Pu Tian, and
Yajun Liang, and
Lun-Xiu Qin, and
Qingcheng Yang, and
Qifeng Yang, and
Lujian Liao, and
Guohong Hu
November 2020,
Journal of biochemistry,
